Hearing loss: an overlooked, modifiable dementia risk factor

In the 2024 Lancet Commission’s model, hearing loss is the single largest modifiable dementia risk factor at the population level, about 7% of cases. That is the part that should stop you: of all the things on that list, hearing is one of the few you can often directly fix, with a device you can buy and wear. Most risk factors ask for a lifetime of discipline. This one asks for a hearing test.

The association behind that 7% is steep. In Lin’s 2011 study, dementia risk climbed with the severity of the loss, and it climbed fast.

How steep the link is

The Lin 2011 numbers are worth seeing side by side, because the pattern (more loss, more risk) is the whole argument for taking even mild loss seriously.

Hearing loss (vs normal)	Dementia risk
Mild	~1.9x
Moderate	~3.0x
Severe	~4.9x
Per 10 decibels of loss	~1.2x

A dose-response curve like this, where the risk rises in step with the loss, is one of the stronger hints that a relationship is real rather than coincidental. It does not prove that treating hearing prevents dementia, which is the harder question, and the reason the trial evidence matters so much.

Why would hearing affect the brain?

There is no single airtight answer, but three explanations are plausible and probably stack on top of each other. The unifying picture: a brain straining to hear is a brain running hot and getting less of what it needs.

• Cognitive load. Picture a phone burning its battery to hold a weak signal. When sound arrives degraded, the brain spends extra effort just decoding speech, effort siphoned away from memory and thinking. Run the brain in that depleted state for years and it may take a toll.
• Reduced stimulation. Thinner auditory input over time may contribute to changes in how the brain maintains itself, including structural changes in the regions that handle sound and memory.
• Social withdrawal. Straining to follow conversations quietly pushes people toward isolation, itself a recognized risk factor, and toward less mental and social stimulation. Hearing loss can drive a second risk factor without anyone noticing.

What the ACHIEVE trial actually found

ACHIEVE, published in The Lancet in 2023, is the test that matters, because it was randomized: it asked whether a hearing intervention (hearing aids plus audiology support) actually slows cognitive decline in adults aged 70 to 84 with untreated hearing loss. The answer has two layers, and skipping either one gets it wrong.

The headline layer: in the primary analysis across the whole study group, the intervention showed no significant effect on three-year cognitive change. The two groups came out essentially identical.

The layer underneath: the cohort came from two different sources, and a prespecified analysis found the intervention worked very differently in each.

• Older participants drawn from a long-running cardiovascular study (ARIC) carried more risk factors and started with lower cognitive scores. In this higher-risk group, the intervention slowed three-year cognitive decline by roughly half (about 48%).
• Healthier community volunteers, who started in better shape, showed essentially no effect.

So the overall result was null, but the benefit landed squarely on the higher-risk older adults, who plausibly include many APOE4 carriers. That is genuinely encouraging, and still a real distance from “hearing aids prevent dementia for everyone.” A prespecified subgroup is a strong lead, not a verdict, and researchers are still untangling it.

The practical takeaway

Here is the part that makes hearing unusual. Even if you set dementia entirely aside, treating hearing loss improves communication, mood, and daily life. So the downside of acting is low, the upside is real, and you do not have to bet on the dementia data resolving in your favor to come out ahead.

• Get your hearing checked, especially from midlife on, and do not wave it off as “everyone mumbles these days.” Hearing loss creeps in gradually, which makes it easy to deny right up until it is significant.
• Take it seriously when it shows up. On an audiogram, loss is graded roughly as mild (25 to 40 dB), moderate (41 to 70 dB), and severe (above 70 dB). In the U.S., over-the-counter hearing aids are now available for mild-to-moderate loss, which drops the cost and hassle barrier a lot. Moderate-to-severe loss is better handled with an audiologist.
• Protect the hearing you still have. Damage starts with sustained exposure above about 85 decibels (busy traffic, power tools, loud earbuds). Noise damage is permanent and entirely preventable, so the cheap win is guarding what you have now.

Common questions

Will hearing aids prevent dementia? Not proven, but promising for higher-risk people, and worth it for quality of life regardless. ACHIEVE’s overall result was null, with the benefit concentrated in the higher-risk subgroup.

When should I get my hearing tested? From midlife on, or any time you catch yourself straining to follow conversations, turning the volume up, or struggling in noisy rooms.

Are cheap OTC hearing aids any good? For mild-to-moderate age-related loss, they can be a reasonable, lower-cost entry point. An audiologist still helps with fitting and with more significant loss.

It is a rare combination: a brain-health lever that is measurable, treatable, and worth pulling for everyday reasons regardless of how the long-term dementia data ultimately shakes out. This is general education, not medical advice.